Skip to main content
Lydia Visser
PhD

My research in the Pathology department is mainly focused on immunological aspects of B-cell lymphoma. I study interactions of tumor cells with the microenvironment, and signaling pathways in Hodgkin lymphoma and non-Hodgkin lymphomas.

Extracellular ligation-dependent CD45RB enzymatic activity negatively regulates lipid raft signal transduction
Published in: Blood
CD45 is the most prominent membrane protein on lymphocytes. The function and regulation of this protein tyrosine phosphatase remain largely obscure, mainly because of the lack of a known ligand, and it still remains unknown whether such tyrosine phosphatases are subject to extracellular control at all. We report that an anti-CD45RB antibody (Ab) that prevents rejection and induces tolerance activates CD45RB tyrosine phosphatase enzymatic activity in T lymphocytes, allowing us to directly monitor the effects of increased CD45RB activity on signal transduction. Using both kinase substrate peptide arrays...
Kaushal Parikh, Sibrand Poppema, Maikel P. Peppelenbosch, Lydia Visser
miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/milk-155 expression
Published in: The Journal of Pathology
Several miRNAs have been reported to be associated with immunoglobulin heavy chain (IgH) mutation and ZAP-70 expression status in blood samples of B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma (B-CLL/SLL). In the bone marrow and lymphoid tissues, proliferation centres (PCs) represent an important site of activation and proliferation of the neoplastic cells, suggesting that these tissues better reflect the biology of CLL than circulating blood cells. We collected 33 lymph nodes and 37 blood CLL samples and analysed IgH mutation status and ZAP-70 expression status. Expression of 15 miRNAs...
M. Wang, L. P. Tan, M. K. Dijkstra, K. van Lom, J-L Robertus, G. Harms, T. Blokzijl, K. Kooistra, M. B. van t'Veer, S. Rosati, L. Visser, M. Jongen-Lavrencic, P. M. Kluin, Anke van den Berg
The CD4+CD26-T-cell population in classical Hodgkin’s lymphoma displays a distinctive regulatory T-cell profile
Published in: Laboratory Investigation
Little is known about the gene expression profile and significance of the rosetting CD4+CD26- T cells in classical Hodgkin’s lymphoma (cHL). To characterize these T cells, CD4+CD26- and CD4+CD26+ T-cell populations were sorted from lymph node (LN) cell suspensions from nodular sclerosis HL (NSHL) and reactive LNs. mRNA profiles of stimulated and resting cell subsets were evaluated with quantitative RT-PCR for 46 genes. We observed a higher percentage of CD4+CD26- T-cells in NSHL than in reactive LNs. The resting CD4+CD26-T cells in NSHL showed higher mRNA levels of...
Yue Ma, Lydia Visser, Tjasso Blokzijl, Geert Harms, Cigdem Atayar, Sibrand Poppema, Anke van den Berg
HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma
Published in: TISSUE ANTIGENS
Classical Hodgkin’s lymphoma (cHL) is characterized by the presence of an abundant reactive infiltrate, lacking effective cytotoxic responses. Especially in Epstein-Barr virus (EBV)-negative cHL, the neoplastic Hodgkin-Reed-Sternberg (HRS) cells have lost protein expression of major histocompatibility complex (MHC) class I, enabling escape from cytotoxic T lymphocyte (CTL) responses. However, downregulation of MHC class I generally induces natural killer (NK) cell activation. The paucity of NK cells in the reactive infiltrate of cHL and the systemic NK cell deficiency observed in cHL patients led us to investigate the expression...
Serum chemokine levels in Hodgkin lymphoma patients: Highly increased levels of CCL17 and CCL22
Published in: British Journal of Haematology
Hodgkin lymphoma (HL) is characterized by a minority of neoplastic Hodgkin-Reed Sternberg (HRS) cells surrounded by a non-neoplastic reactive infiltrate. As immunological mechanisms appear to be crucial in classical HL pathogenesis, altered serum chemokine levels might be related to disease activity. Serum levels of nine chemokines were examined in 163 untreated HL patients and 334 controls. We investigated single nucleotide polymorphisms (SNPs) for association with serum CCL17 (thymus and activation-regulated chemokine, TARC) levels and HL susceptibility. Serum CCL17 and CCL22 (macrophage-derived chemokine, MDC) levels were significantly increased in...
Marijke Niens, Lydia Visser, I.M Nolte, Gerrit van der Steege, Arjan Diepstra, P. Cordano, R.F. Jarrett, G.J. te Meerman, Sibrand Poppema, Anke van den Berg